(marketscreener.com) TORONTO, Nov. 30, 2023 — RAMM Pharma Corp. , announces that it has rescinded a grant of 2,000,000 stock options made to the chief operating officer of Canapar Corp., a subsidiary of the Company. About RAMM Pharma Corp. RAMM Pharma is a l…

TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the Company or “RAMM”) (CSE: RAMM), announces that it has rescinded a grant of 2,000,000 stock o…